Search

Your search keyword '"Boeve, Bradley F"' showing total 3,625 results

Search Constraints

Start Over You searched for: Author "Boeve, Bradley F" Remove constraint Author: "Boeve, Bradley F"
3,625 results on '"Boeve, Bradley F"'

Search Results

1. Investigation of the genetic aetiology of Lewy body diseases with and without dementia

2. Whole genome‐wide sequence analysis of long‐lived families (Long‐Life Family Study) identifies MTUS2 gene associated with late‐onset Alzheimer's disease

3. The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology

4. Examining Associations Between Smartphone Use and Clinical Severity in Frontotemporal Dementia: Proof-of-Concept Study

5. Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum

6. Grey matter networks in women and men with dementia with Lewy bodies

7. Influences of amyloid-β and tau on white matter neurite alterations in dementia with Lewy bodies

8. HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases

9. Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion

10. Role of GBA variants in Lewy body disease neuropathology

11. Scientific commentary on: “Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies”

12. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

13. Feasibility and acceptability of remote smartphone cognitive testing in frontotemporal dementia research

14. Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia

15. Publisher Correction: The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology

16. The contribution of behavioral features to caregiver burden in FTLD spectrum disorders

17. Promoting Growth in Behavioral Neurology: A Path Forward

18. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.

19. Alzheimer Disease Cerebrospinal Fluid Biomarkers in a Tertiary Neurology Practice

20. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

21. TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains

22. MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies

23. Proposed research criteria for prodromal behavioural variant frontotemporal dementia

24. Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders

25. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases

26. TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A

27. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study

29. Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium

30. Detection of emerging neurodegeneration using Bayesian linear mixed-effect modeling

31. Demographic and psychosocial factors associated with the decision to learn mutation status in familial frontotemporal dementia and the impact of disclosure on mood

32. Gearing up for the future: Exploring facilitators and barriers to inform clinical trial design in frontotemporal lobar degeneration

33. Presymptomatic and symptomatic MAPT mutation carriers feature functional connectivity alterations

34. Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic

35. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

36. Neurite-based white matter alterations in MAPT mutation carriers: A multi-shell diffusion MRI study in the ALLFTD consortium

37. Assessing network degeneration and phenotypic heterogeneity in genetic frontotemporal lobar degeneration by decoding FDG-PET

38. Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia.

39. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration

40. Uniform data set language measures for bvFTD and PPA diagnosis and monitoring

41. Brain volumetric deficits in MAPT mutation carriers: a multisite study

42. Studying the natural history of frontotemporal lobar degeneration (FTLD): The ARTFL LEFFTDS longitudinal FTLD (ALLFTD) protocol

43. Plasma neurofilament light chain levels reflect caregiver burden and social cognition measures in familial frontotemporal lobar degeneration (FTLD)

44. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

45. Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort

46. Longitudinal structural and metabolic changes in frontotemporal dementia.

47. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

48. Research criteria for the diagnosis of prodromal dementia with Lewy bodies

49. Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study

50. Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.

Catalog

Books, media, physical & digital resources